查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
重組白蛋白市場規模及預測（2021-2031年），全球及區域佔有率、趨勢及成長機會分析報告涵蓋範圍：依來源、應用及最終用戶分類
市場調查報告書
商品編碼
1906685

重組白蛋白市場規模及預測（2021-2031年），全球及區域佔有率、趨勢及成長機會分析報告涵蓋範圍：依來源、應用及最終用戶分類

Recombinant Albumin Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 237 Pages | 訂單完成後即時交付

價格
根據我們最新發布的題為「2031年重組白蛋白市場預測——全球分析——按應用和最終用戶分類」的研究報告，預計該市場將從2024年的3.925億美元成長到2031年的7.6754億美元；2025年至2031年期間，該市場預計將以10.1%的複合年成長率成長。重組白蛋白市場的成長歸因於肝病及相關疾病盛行率的上升、生物技術製造和產品開發的進步，以及重症監護和急救環境中對白蛋白需求的成長。

重組白蛋白是一種合成的、非動物來源的人血清白蛋白 (HSA)，透過基因工程技術在酵母（畢赤酵母、釀酒酵母）、水稻或大腸桿菌等宿主生物中生產。其胺基酸序列與天然 HSA 完全相同，但完全不含血漿來源白蛋白中常見的血源性病原體、朊病毒和病毒污染物。重組白蛋白在 cGMP 條件下生產，具有優異的批間一致性、可擴展性和符合監管規定的安全性。它廣泛用作生物療法藥物和疫苗的穩定劑/賦形劑，是生物製劑和細胞/基因治療無血清細胞培養基的關鍵成分，也是治療低白蛋白血症、肝病和再生醫學的新興療法。

北美重組白蛋白市場分為美國、加拿大和墨西哥三個部分。受臨床對更安全、更穩定的血漿蛋白產品需求不斷成長的推動，北美重組白蛋白市場正經歷顯著成長。據美國食品藥物管理局（FDA）稱，需要白蛋白治療的疾病（例如肝硬化、燒傷和休克）的發生率顯著增加。美國疾病管制與預防中心（CDC）報告稱，截至2023年，美國每年新增肝硬化病例約4萬例。生物技術的進步也促進了重組白蛋白的日益普及，推動了更安全、可規模化生產且符合倫理道德的產品的開發。值得注意的是，FDA於2022年批准了新的重組白蛋白製劑，與血漿衍生產品相比，這些製劑降低了病原體傳播的風險，符合人們日益成長的安全擔憂。持續的研究和產品創新，例如用於重症監護和腫瘤治療的重組白蛋白療法的推出，進一步推動了市場擴張。政府的各項舉措，包括資助生物技術研究和加強對血漿衍生產品的監管，都促進了向重組替代療法的轉變。新冠疫情凸顯了可靠生物製藥的重要性，進一步加速了市場成長。截至2024年，監管機構繼續認可重組白蛋白是更安全的白蛋白療法選擇。

美國面臨對更安全的生物製劑的需求、肝病盛行率的上升以及監管預期不斷變化等挑戰。近期一項研究發現，美國成年人口中肝硬化的盛行率為2.6%。肝硬化患者常出現低白蛋白血症，需補充白蛋白。美國食品藥物管理局（FDA）於2024年4月發布了一份題為「在細胞和基因治療以及組織工程醫療產品生產中使用人源和動物源材料的考量」的指導草案。在該草案中，FDA強調了在先進療法中使用人源或動物源材料（例如白蛋白和飼料）的擔憂，並鼓勵生產商證明替代方案的合理性。這一監管趨勢使得重組人血清白蛋白（rHSA）和其他非血漿來源的白蛋白產品作為更安全、成分明確的替代方案佔據了有利地位。

血漿來源白蛋白的治療性替代療法將在未來提供市場機會

重組人血清白蛋白的一大發展機會在於替代血漿來源的人血清白蛋白（HSA）用於治療，從而解決安全性和血漿供應方面的限制。根據武漢市衛生健康委員會預測，到2024年，中國的人血清白蛋白需求量將超過1,000噸，其中進口量佔總供應量的69%以上。為減少對血漿進口的依賴，國家藥品監督管理局（NMPA）於2025年7月批准了武漢希格生物技術有限公司研發的全球首個米來源重組人血清白蛋白注射液。在印度，Shilpa Medicare Ltd.於2024年8月成為首家完成重組人血清白蛋白（20%）I期臨床試驗的國內企業，並於2024年11月獲得印度中央藥品標準控制組織（CDSCO）的III期臨床試驗批准。這些監管里程碑標誌著人們對重組技術的信心日益增強。隨著肝硬化和低白蛋白血症在全球範圍內的日益增多，重組人類血清白蛋白有望成為一種可擴展、無病原體的替代療法。

目錄

第1章：引言

第2章：執行概要

  • 分析師市場展望
  • 市場吸引力

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：
  • 假設和局限性

第4章：重組白蛋白市場概況

  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：重組白蛋白市場－主要市場動態

  • 重組白蛋白市場－主要市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來趨勢
  • 駕駛員和安全帶的影響：

第6章：重組白蛋白市場－全球市場分析

  • 重組白蛋白市場收入，2021-2031年
  • 重組白蛋白市場預測分析

第7章：重組白蛋白市場分析－依來源

  • 人類重組白蛋白
  • 牛重組白蛋白
  • 其他來源

第8章：重組白蛋白市場分析－按應用領域分類

  • 生物治療藥物和疫苗中的輔料
  • 細胞培養
  • 藥物遞送
  • 診斷
  • 其他應用

第9章：重組白蛋白市場分析－依最終使用者分類

  • 製藥和生物技術公司
  • 研究機構
  • 醫院和診斷實驗室
  • 其他最終用戶

第10章：重組白蛋白市場－地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第11章：競爭格局

  • 關鍵參與者熱力圖分析
  • 公司市佔率分析，2024 年

第12章：行業概況

  • 市場拓展計劃
  • 併購
  • 其他進展

第13章：公司簡介

  • CSL Ltd
  • Merck KGaA
  • HiMedia Laboratories Pvt Ltd
  • Thermo Fisher Scientific Inc
  • InVitria
  • Medxbio Pte Ltd
  • Lazuline Biotech Private Limited
  • Cyagen Biosciences
  • Sartorius AG
  • Akron Biotech

第14章：附錄

Product Code: TIPRE00041695

According to our new research study on "Recombinant Albumin Market Forecast to 2031 -Global Analysis - by Application and End User," the market is anticipated to grow from US$ 392.50 million in 2024 to US$ 767.54 million by 2031; the market is expected to register a CAGR of 10.1% from 2025 to 2031. The Recombinant Albumin Market growth is attributed to the increasing prevalence of liver diseases and associated conditions, advancements in biotechnological manufacturing and product development, and growing demand for albumin in critical care and emergency settings.

Recombinant albumin is a synthetic, non-animal-derived version of human serum albumin (HSA) produced through genetic engineering in host organisms such as yeast (Pichia pastoris, Saccharomyces cerevisiae), rice (Oryza sativa), or bacteria (E. coli). It is 100% identical in amino acid sequence to natural HSA but completely free of blood-borne pathogens, prions, and viral contaminants associated with plasma-derived albumin. Recombinant albumin is manufactured under cGMP conditions, offering superior batch-to-batch consistency, scalability, and regulatory safety. It is widely used as a stabilizer/excipient in biotherapeutics and vaccines, a critical component in serum-free cell culture media for biologics and cell/gene therapies, and an emerging therapeutic for hypoalbuminemia, liver disease, and regenerative medicine applications.

The Recombinant Albumin market in North America is segmented into the US, Canada, and Mexico. The recombinant albumin market in North America is experiencing significant growth driven by increasing clinical demand for safer and more consistent plasma protein products. According to the U.S. FDA, the prevalence of conditions requiring albumin therapy-such as liver cirrhosis, burns, and shock-has increased significantly. The CDC reported an estimated 40,000 new cases of liver cirrhosis annually in the US as of 2023. The growing adoption of recombinant albumin is also supported by advancements in biotechnology, leading to the development of safer, scalable, and ethically sustainable products. Notably, in 2022, the FDA approved new recombinant albumin formulations that reduce the risk of pathogen transmission compared to plasma-derived options, aligning with increasing safety concerns. Ongoing research and product innovations, such as the launch of recombinant albumin-based therapies for critical care and oncology, fuel market expansion. Government initiatives, including funding for biotechnology research and stricter regulations on plasma-derived products, encourage the shift toward recombinant alternatives. The COVID-19 pandemic underscored the importance of reliable biopharmaceuticals, further accelerating market growth. As of 2024, regulatory agencies continued to endorse recombinant albumin as a safer option for albumin therapies.

The US witnesses a demand for safer biologic inputs, rising prevalence of liver disease, and evolving regulatory expectations. A recent study found the prevalence of cirrhosis to be 2.6% of the US adult population. Individuals with liver cirrhosis often develop hypoalbuminemia and require albumin administration. The Food and Drug Administration (FDA) issued a draft guidance in April 2024 titled "Considerations for the Use of Human-and Animal-Derived Materials in the Manufacture of Cell and Gene Therapy and Tissue-Engineered Medical Products." In this draft, the agency highlighted concerns over the use of human- or animal-derived materials such as albumin and feeds in advanced therapies and encouraged manufacturers to justify alternatives. This regulatory momentum places recombinant human serum albumin (rHSA) and other non-plasma-derived albumin products in a favorable position as safer, defined alternatives.

Therapeutic Substitution of Plasma-Derived Albumin to Provide Market Opportunities in Future

A major opportunity for recombinant albumin lies in replacing plasma-derived human serum albumin (HSA) for therapeutic use, addressing safety and plasma-supply constraints. In China, human albumin demand exceeded 1,000 tons in 2024, with imports accounting for over 69% of total supply, according to the Wuhan Municipal Health Commission. To reduce reliance on plasma imports, the National Medical Products Administration (NMPA) approved the world's first rice-derived recombinant human albumin injection developed by Wuhan Healthgen Biotechnology in July 2025. In India, Shilpa Medicare Ltd. became the first domestic company to complete Phase I clinical trials for recombinant human albumin (20%) in August 2024, with Phase III trials authorized by CDSCO in November 2024. These regulatory milestones mark growing confidence in recombinant technology. With liver cirrhosis and hypoalbuminemia increasing globally, recombinant albumin presents a scalable, pathogen-free therapeutic substitute.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the Recombinant Albumin market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Recombinant Albumin Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Recombinant Albumin Market - Key Market Dynamics

  • 5.1 Recombinant Albumin Market - Key Market Dynamics
  • 5.2 Market Drivers
  • 5.3 Market Restraints
  • 5.4 Market Opportunities
  • 5.5 Future Trends
  • 5.6 Impact of Drivers and Restraints:

6. Recombinant Albumin Market - Global Market Analysis

  • 6.1 Recombinant Albumin Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Recombinant Albumin Market Forecast Analysis

7. Recombinant Albumin Market Analysis - by Source

  • 7.1 Human Recombinant Albumin
    • 7.1.1 Overview
    • 7.1.2 Human Recombinant Albumin: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Bovine Recombinant Albumin
    • 7.2.1 Overview
    • 7.2.2 Bovine Recombinant Albumin: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.3 Other Sources
    • 7.3.1 Overview
    • 7.3.2 Other Sources: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Recombinant Albumin Market Analysis - by Application

  • 8.1 Excipient in Biotherapeutics and Vaccines
    • 8.1.1 Overview
    • 8.1.2 Excipient in Biotherapeutics and Vaccines: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.3 Drug Delivery
    • 8.3.1 Overview
    • 8.3.2 Drug Delivery: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.4 Diagnostics
    • 8.4.1 Overview
    • 8.4.2 Diagnostics: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.5 Other Applications
    • 8.5.1 Overview
    • 8.5.2 Other Applications: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Recombinant Albumin Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.2 Research Institutes
    • 9.2.1 Overview
    • 9.2.2 Research Institutes: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.3 Hospitals and Diagnostic Laboratories
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Laboratories: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.4 Others End Users
    • 9.4.1 Overview
    • 9.4.2 Others End Users: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)

10. Recombinant Albumin Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Recombinant Albumin Market Overview
    • 10.2.2 North America: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
    • 10.2.3 North America: Recombinant Albumin Market Breakdown, by Source
      • 10.2.3.1 North America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Source
    • 10.2.4 North America: Recombinant Albumin Market Breakdown, by Application
      • 10.2.4.1 North America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: Recombinant Albumin Market Breakdown, by End User
      • 10.2.5.1 North America: Recombinant Albumin Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.2.6.2.1 United States: Recombinant Albumin Market Breakdown, by Source
        • 10.2.6.2.2 United States: Recombinant Albumin Market Breakdown, by Application
        • 10.2.6.2.3 United States: Recombinant Albumin Market Breakdown, by End User
      • 10.2.6.3 Canada: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.2.6.3.1 Canada: Recombinant Albumin Market Breakdown, by Source
        • 10.2.6.3.2 Canada: Recombinant Albumin Market Breakdown, by Application
        • 10.2.6.3.3 Canada: Recombinant Albumin Market Breakdown, by End User
      • 10.2.6.4 Mexico: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.2.6.4.1 Mexico: Recombinant Albumin Market Breakdown, by Source
        • 10.2.6.4.2 Mexico: Recombinant Albumin Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: Recombinant Albumin Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Recombinant Albumin Market Overview
    • 10.3.2 Europe: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
    • 10.3.3 Europe: Recombinant Albumin Market Breakdown, by Source
      • 10.3.3.1 Europe: Recombinant Albumin Market - Revenue and Forecast Analysis - by Source
    • 10.3.4 Europe: Recombinant Albumin Market Breakdown, by Application
      • 10.3.4.1 Europe: Recombinant Albumin Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: Recombinant Albumin Market Breakdown, by End User
      • 10.3.5.1 Europe: Recombinant Albumin Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.3.6.2.1 Germany: Recombinant Albumin Market Breakdown, by Source
        • 10.3.6.2.2 Germany: Recombinant Albumin Market Breakdown, by Application
        • 10.3.6.2.3 Germany: Recombinant Albumin Market Breakdown, by End User
      • 10.3.6.3 United Kingdom: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.3.6.3.1 United Kingdom: Recombinant Albumin Market Breakdown, by Source
        • 10.3.6.3.2 United Kingdom: Recombinant Albumin Market Breakdown, by Application
        • 10.3.6.3.3 United Kingdom: Recombinant Albumin Market Breakdown, by End User
      • 10.3.6.4 France: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.3.6.4.1 France: Recombinant Albumin Market Breakdown, by Source
        • 10.3.6.4.2 France: Recombinant Albumin Market Breakdown, by Application
        • 10.3.6.4.3 France: Recombinant Albumin Market Breakdown, by End User
      • 10.3.6.5 Spain: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.3.6.5.1 Spain: Recombinant Albumin Market Breakdown, by Source
        • 10.3.6.5.2 Spain: Recombinant Albumin Market Breakdown, by Application
        • 10.3.6.5.3 Spain: Recombinant Albumin Market Breakdown, by End User
      • 10.3.6.6 Italy: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.3.6.6.1 Italy: Recombinant Albumin Market Breakdown, by Source
        • 10.3.6.6.2 Italy: Recombinant Albumin Market Breakdown, by Application
        • 10.3.6.6.3 Italy: Recombinant Albumin Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.3.6.7.1 Rest of Europe: Recombinant Albumin Market Breakdown, by Source
        • 10.3.6.7.2 Rest of Europe: Recombinant Albumin Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: Recombinant Albumin Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Recombinant Albumin Market Overview
    • 10.4.2 Asia Pacific: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
    • 10.4.3 Asia Pacific: Recombinant Albumin Market Breakdown, by Source
      • 10.4.3.1 Asia Pacific: Recombinant Albumin Market - Revenue and Forecast Analysis - by Source
    • 10.4.4 Asia Pacific: Recombinant Albumin Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: Recombinant Albumin Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: Recombinant Albumin Market Breakdown, by End User
      • 10.4.5.1 Asia Pacific: Recombinant Albumin Market - Revenue and Forecast Analysis - by End User
    • 10.4.6 Asia Pacific: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 China: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.4.6.2.1 China: Recombinant Albumin Market Breakdown, by Source
        • 10.4.6.2.2 China: Recombinant Albumin Market Breakdown, by Application
        • 10.4.6.2.3 China: Recombinant Albumin Market Breakdown, by End User
      • 10.4.6.3 Japan: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.4.6.3.1 Japan: Recombinant Albumin Market Breakdown, by Source
        • 10.4.6.3.2 Japan: Recombinant Albumin Market Breakdown, by Application
        • 10.4.6.3.3 Japan: Recombinant Albumin Market Breakdown, by End User
      • 10.4.6.4 India: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.4.6.4.1 India: Recombinant Albumin Market Breakdown, by Source
        • 10.4.6.4.2 India: Recombinant Albumin Market Breakdown, by Application
        • 10.4.6.4.3 India: Recombinant Albumin Market Breakdown, by End User
      • 10.4.6.5 Australia: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.4.6.5.1 Australia: Recombinant Albumin Market Breakdown, by Source
        • 10.4.6.5.2 Australia: Recombinant Albumin Market Breakdown, by Application
        • 10.4.6.5.3 Australia: Recombinant Albumin Market Breakdown, by End User
      • 10.4.6.6 South Korea: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.4.6.6.1 South Korea: Recombinant Albumin Market Breakdown, by Source
        • 10.4.6.6.2 South Korea: Recombinant Albumin Market Breakdown, by Application
        • 10.4.6.6.3 South Korea: Recombinant Albumin Market Breakdown, by End User
      • 10.4.6.7 Rest of APAC: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.4.6.7.1 Rest of APAC: Recombinant Albumin Market Breakdown, by Source
        • 10.4.6.7.2 Rest of APAC: Recombinant Albumin Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: Recombinant Albumin Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Recombinant Albumin Market Overview
    • 10.5.2 Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
    • 10.5.3 Middle East and Africa: Recombinant Albumin Market Breakdown, by Source
      • 10.5.3.1 Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast Analysis - by Source
    • 10.5.4 Middle East and Africa: Recombinant Albumin Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: Recombinant Albumin Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.5.6.2.1 Saudi Arabia: Recombinant Albumin Market Breakdown, by Source
        • 10.5.6.2.2 Saudi Arabia: Recombinant Albumin Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: Recombinant Albumin Market Breakdown, by End User
      • 10.5.6.3 South Africa: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.5.6.3.1 South Africa: Recombinant Albumin Market Breakdown, by Source
        • 10.5.6.3.2 South Africa: Recombinant Albumin Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: Recombinant Albumin Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.5.6.4.1 United Arab Emirates: Recombinant Albumin Market Breakdown, by Source
        • 10.5.6.4.2 United Arab Emirates: Recombinant Albumin Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: Recombinant Albumin Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.5.6.5.1 Rest of Middle East and Africa: Recombinant Albumin Market Breakdown, by Source
        • 10.5.6.5.2 Rest of Middle East and Africa: Recombinant Albumin Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: Recombinant Albumin Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Recombinant Albumin Market Overview
    • 10.6.2 South and Central America: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
    • 10.6.3 South and Central America: Recombinant Albumin Market Breakdown, by Source
      • 10.6.3.1 South and Central America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Source
    • 10.6.4 South and Central America: Recombinant Albumin Market Breakdown, by Application
      • 10.6.4.1 South and Central America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: Recombinant Albumin Market Breakdown, by End User
      • 10.6.5.1 South and Central America: Recombinant Albumin Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: Recombinant Albumin Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.6.6.2.1 Brazil: Recombinant Albumin Market Breakdown, by Source
        • 10.6.6.2.2 Brazil: Recombinant Albumin Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: Recombinant Albumin Market Breakdown, by End User
      • 10.6.6.3 Argentina: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.6.6.3.1 Argentina: Recombinant Albumin Market Breakdown, by Source
        • 10.6.6.3.2 Argentina: Recombinant Albumin Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: Recombinant Albumin Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 10.6.6.4.1 Rest of South and Central America: Recombinant Albumin Market Breakdown, by Source
        • 10.6.6.4.2 Rest of South and Central America: Recombinant Albumin Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: Recombinant Albumin Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Market Initiative
  • 12.3 Merger and Acquisition
  • 12.4 Other Developments

13. Company Profiles

  • 13.1 CSL Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Merck KGaA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 HiMedia Laboratories Pvt Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Thermo Fisher Scientific Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 InVitria
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Medxbio Pte Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Lazuline Biotech Private Limited
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Cyagen Biosciences
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Sartorius AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Akron Biotech
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 List of Abbreviations

List Of Tables

  • Table 1. Recombinant Albumin Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand)
  • Table 4. Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand)
  • Table 5. Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 6. Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 7. Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 8. Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 9. Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 10. Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 11. North America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 12. North America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 13. North America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 14. North America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 15. North America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 16. North America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 17. North America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Country
  • Table 18. North America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Country
  • Table 19. United States: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 20. United States: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 21. United States: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 22. United States: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 23. United States: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 24. United States: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 25. Canada: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 26. Canada: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 27. Canada: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 28. Canada: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 29. Canada: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 30. Canada: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 31. Mexico: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 32. Mexico: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 33. Mexico: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 34. Mexico: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 35. Mexico: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 36. Mexico: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 37. Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 38. Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 39. Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 40. Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 41. Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 42. Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 43. Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Country
  • Table 44. Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Country
  • Table 45. Germany: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 46. Germany: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 47. Germany: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 48. Germany: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 49. Germany: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 50. Germany: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 51. United Kingdom: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 52. United Kingdom: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 53. United Kingdom: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 54. United Kingdom: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 55. United Kingdom: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 56. United Kingdom: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 57. France: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 58. France: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 59. France: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 60. France: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 61. France: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 62. France: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 63. Spain: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 64. Spain: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 65. Spain: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 66. Spain: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 67. Spain: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 68. Spain: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 69. Italy: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 70. Italy: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 71. Italy: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 72. Italy: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 73. Italy: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 74. Italy: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 75. Rest of Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 76. Rest of Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 77. Rest of Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 78. Rest of Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 79. Rest of Europe: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 80. Rest of Europe: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 81. Asia Pacific: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 82. Asia Pacific: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 83. Asia Pacific: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 84. Asia Pacific: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 85. Asia Pacific: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 86. Asia Pacific: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 87. Asia Pacific: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Country
  • Table 88. Asia Pacific: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Country
  • Table 89. China: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 90. China: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 91. China: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 92. China: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 93. China: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 94. China: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 95. Japan: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 96. Japan: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 97. Japan: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 98. Japan: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 99. Japan: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 100. Japan: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 101. India: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 102. India: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 103. India: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 104. India: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 105. India: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 106. India: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 107. Australia: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 108. Australia: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 109. Australia: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 110. Australia: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 111. Australia: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 112. Australia: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 113. South Korea: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 114. South Korea: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 115. South Korea: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 116. South Korea: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 117. South Korea: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 118. South Korea: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 119. Rest of APAC: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 120. Rest of APAC: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 121. Rest of APAC: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 122. Rest of APAC: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 123. Rest of APAC: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 124. Rest of APAC: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 125. Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 126. Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 127. Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 128. Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 129. Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 130. Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 131. Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Country
  • Table 132. Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Country
  • Table 133. Saudi Arabia: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 134. Saudi Arabia: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 135. Saudi Arabia: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 136. Saudi Arabia: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 137. Saudi Arabia: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 138. Saudi Arabia: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 139. South Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 140. South Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 141. South Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 142. South Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 143. South Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 144. South Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 145. United Arab Emirates: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 146. United Arab Emirates: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 147. United Arab Emirates: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 148. United Arab Emirates: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 149. United Arab Emirates: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 150. United Arab Emirates: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 151. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 152. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 153. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 154. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 155. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 156. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 157. South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 158. South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 159. South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 160. South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 161. South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 162. South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 163. South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Country
  • Table 164. South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Country
  • Table 165. Brazil: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 166. Brazil: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 167. Brazil: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 168. Brazil: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 169. Brazil: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 170. Brazil: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 171. Argentina: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 172. Argentina: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 173. Argentina: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 174. Argentina: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 175. Argentina: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 176. Argentina: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 177. Rest of South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Source
  • Table 178. Rest of South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Source
  • Table 179. Rest of South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by Application
  • Table 180. Rest of South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by Application
  • Table 181. Rest of South and Central America: Recombinant Albumin Market - Revenue, 2021-2024 (US$ Thousand) - by End User
  • Table 182. Rest of South and Central America: Recombinant Albumin Market - Revenue Forecast, 2025-2031 (US$ Thousand) - by End User
  • Table 183. List of Abbreviations

List Of Figures

  • Figure 1. Recombinant Albumin Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Recombinant Albumin Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Recombinant Albumin Market Share (%) - by Source (2024 and 2031)
  • Figure 6. Human Recombinant Albumin: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 7. Bovine Recombinant Albumin: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Other Sources: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Recombinant Albumin Market Share (%) - by Application (2024 and 2031)
  • Figure 10. Excipient in Biotherapeutics and Vaccines: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 11. Cell Culture: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Drug Delivery: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Diagnostics: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. Other Applications: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 15. Recombinant Albumin Market Share (%) - by End User (2024 and 2031)
  • Figure 16. Pharmaceutical and Biotechnology Companies: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 17. Research Institutes: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 18. Hospitals and Diagnostic Laboratories: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 19. Others End Users: Recombinant Albumin Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 20. Recombinant Albumin Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 21. North America: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
  • Figure 22. North America: Recombinant Albumin Market Breakdown, by Source (2024 and 2031)
  • Figure 23. North America: Recombinant Albumin Market Breakdown, by Application (2024 and 2031)
  • Figure 24. North America: Recombinant Albumin Market Breakdown, by End User (2024 and 2031)
  • Figure 25. North America: Recombinant Albumin Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 26. United States: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 27. Canada: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 28. Mexico: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 29. Europe: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
  • Figure 30. Europe: Recombinant Albumin Market Breakdown, by Source (2024 and 2031)
  • Figure 31. Europe: Recombinant Albumin Market Breakdown, by Application (2024 and 2031)
  • Figure 32. Europe: Recombinant Albumin Market Breakdown, by End User (2024 and 2031)
  • Figure 33. Europe: Recombinant Albumin Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 34. Germany: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 35. United Kingdom: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 36. France: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 37. Spain: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 38. Italy: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 39. Rest of Europe: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 40. Asia Pacific: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
  • Figure 41. Asia Pacific: Recombinant Albumin Market Breakdown, by Source (2024 and 2031)
  • Figure 42. Asia Pacific: Recombinant Albumin Market Breakdown, by Application (2024 and 2031)
  • Figure 43. Asia Pacific: Recombinant Albumin Market Breakdown, by End User (2024 and 2031)
  • Figure 44. Asia Pacific: Recombinant Albumin Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 45. China: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 46. Japan: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 47. India: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 48. Australia: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 49. South Korea: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 50. Rest of APAC: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 51. Middle East and Africa: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
  • Figure 52. Middle East and Africa: Recombinant Albumin Market Breakdown, by Source (2024 and 2031)
  • Figure 53. Middle East and Africa: Recombinant Albumin Market Breakdown, by Application (2024 and 2031)
  • Figure 54. Middle East and Africa: Recombinant Albumin Market Breakdown, by End User (2024 and 2031)
  • Figure 55. Middle East and Africa: Recombinant Albumin Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 56. Saudi Arabia: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 57. South Africa: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 58. United Arab Emirates: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 59. Rest of Middle East and Africa: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 60. South and Central America: Recombinant Albumin Market - Revenue, 2021-2031 (US$ Thousand)
  • Figure 61. South and Central America: Recombinant Albumin Market Breakdown, by Source (2024 and 2031)
  • Figure 62. South and Central America: Recombinant Albumin Market Breakdown, by Application (2024 and 2031)
  • Figure 63. South and Central America: Recombinant Albumin Market Breakdown, by End User (2024 and 2031)
  • Figure 64. South and Central America: Recombinant Albumin Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 65. Brazil: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 66. Argentina: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 67. Rest of South and Central America: Recombinant Albumin Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 68. Company Market Share Analysis, 2024